Current role
Biotechnology · Healthcare
Board Member
2021-06-23–present
Kirk Ways, M.D., Ph.D.
Equibles does not estimate personal net worth.
Get an email with a short summary when Spruce Biosciences, Inc. publishes a filing, an earnings call transcript or a press release.
Get SPRB alertsAbout Kirk Ways, M.D., Ph.D.
Kirk Ways, M.D., Ph.D. is recorded as Board Member at Spruce Biosciences, Inc. (SPRB) since June 23, 2021. Spruce Biosciences, Inc. reported in an 8-K filed December 27, 2024 that Kirk Ways, M.D., Ph.D. was appointed interim Chief Medical Officer, effective December 20, 2024. Spruce Biosciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Spruce Biosciences, Inc. includes Javier Szwarcberg (CEO and Board Member), Michael Grey (Chairman), Samir Gharib (CFO) and 2 others.
“Kirk Ways, M.D., Ph.D., 73, who has served on the Company’s Board of Directors since June 2021, will serve as the Company’s interim Chief Medical Officer effective December 20, 2024.”
Affiliation history
-
Spruce Biosciences, Inc. (SPRB)
SEC 8-K
Current2024-12-20–present
-
Current
2021-06-23–present
Company network
Leadership on record at Spruce Biosciences, Inc.
- Javier Szwarcberg CEO, Board Member
- Michael Grey Chairman
- Samir Gharib CFO
- Keli Walbert Board Member
- Percival Barretto-Ko Board Member